MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve damage develops.

The company recently hit significant roadblocks with its BTK inhibitor, but there are plenty of fish in the sea for the drug ...

Find Therapeutics secured CA$10 million in funding to continue advancing tasronetide, its treatment to restore damaged myelin ...

Dr. Friese is being honored for his pioneering work discovering how inflammation is associated with nerve cell death in multiple sclerosis.

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous system and scrambles communication between the brain and body. MS, for which ...

MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...

BARCELONA, Spain — In a noninferiority trial in pediatric-onset multiple sclerosis (POMS), ocrelizumab met its primary endpoint compared with fingolimod, demonstrating better tolerability and greater ...

Get all latest & breaking news on Multiple Sclerosis. Watch videos, top stories and articles on Multiple Sclerosis at moneycontrol.com.